NeoGenomics’ Pharma Services offer two multiplex immunofluorescence platforms: MultiOmyx™ and PhenoImager™ HT
MultiOmyx™ is a proprietary, high-order multiplexing methodology that enables visualization and characterization of up to 60 proteins in a single FFPE tissue section.
High order ≥ 7 plex
Comprehensive analysis of tumor biology
Deep & precise immuno-profiling
PhenoImager™ HT (formerly Vectra Polaris) is an automated system that allows simultaneous detection of 2-6 different markers from a single FFPE tissue slide which would provide a streamlined workflow for implementing refined low-order multiplex panel sets.
Low order 2-6 plex
High-throughput & faster TAT
Assay transfer & validation
Optimization of an Integrated MultiOmyx-RNAscopehyperplexassay for co-detection and characterization of multiple protein and RNA biomarkers within the tumor microenvironment (TME)
Characterizing CD39 and CD73 cell subtypes in the tumor microenvironment using MultiOmyx immunofluorescence assay
Comprehensive analysis of natural killer cell-associated markers using MultiOmyx immunofluorescence assay
Contact Us To Get Started!
Work with us – your premier oncology partner – to optimize cancer care for patients